---
title: "Miltefosine - Visceral Leishmaniasis"
sidebar: mydoc_sidebar
permalink: db09031-mesh-d007898-1.html
toc: false 
---


Path ID: `DB09031_MESH_D007898_1`
{% include image.html url="images/db09031-mesh-d007898-1.png" file="db09031-mesh-d007898-1.png" alt="db09031-mesh-d007898-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C039128">MESH:C039128 </a> | miltefosine | Drug |
| <a href="https://identifiers.org/MESH:D045304">MESH:D045304 </a> | Cytochromes c | GeneFamily |
| <a href="https://identifiers.org/CHEBI:16247">CHEBI:16247 </a> | phospholipid | ChemicalSubstance |
| <a href="https://identifiers.org/CHEBI:15889">CHEBI:15889 </a> | sterol | ChemicalSubstance |
| <a href="https://identifiers.org/taxonomy:5661">taxonomy:5661 </a> | Leishmania donovani | OrganismTaxon |
| <a href="https://identifiers.org/MESH:D007898">MESH:D007898 </a> | Visceral leishmaniasis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Miltefosine | DISRUPTS | Phospholipid |
| Miltefosine | DISRUPTS | Sterol |
| Phospholipid | IN TAXON | Leishmania Donovani |
| Sterol | IN TAXON | Leishmania Donovani |
| Miltefosine | NEGATIVELY CORRELATED WITH | Cytochromes C |
| Cytochromes C | IN TAXON | Leishmania Donovani |
| Leishmania Donovani | CAUSES | Visceral Leishmaniasis |
|---------|-----------|---------|

Comment: The chosen MESH term is the most generic term that encompasses ALL Cytochromes C, whereas InterPro and Pfam have terms to encompass specific types of cytochrome C e.g. Cytochrome c oxidase subunit IV superfamily (IPR036639).

Reference: 
  - [https://go.drugbank.com/drugs/DB09031](https://go.drugbank.com/drugs/DB09031)
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204684s000lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204684s000lbl.pdf)
